FrieslandCampina Ingredients secures EU approval for protein hydrolysate in infant and follow-on formulas

FrieslandCampina Ingredients is proud to announce that its Hyvital^® Whey HA 300, a protein hydrolysate specifically developed for infant and follow-on formulas, has received approval for use across the European Union. This approval follows a rigorous scientific evaluation under the EU’s latest regulations, ensuring compliance with the highest safety and suitability standards.

Protein hydrolysates, produced through the enzymatic hydrolysis of milk proteins, provide infant formula manufacturers with an option to enhance their formulas and better meet the specific nutritional needs of infants. Although Hyvital^® Whey HA 300 has been on the market since 2010, changes in EU regulations in February 2022 required a new safety and suitability evaluation for protein hydrolysates used in standard infant nutrition.

After having successfully passed this scientific evaluation, and subsequent approval by the European commission, Hyvital^® Whey HA 300 is now one of only a few milk hydrolysate ingredients that is included in the Commission Delegated Regulation (EU) 2016/127 – the final step required for its use in infant and follow-on formulas sold throughout the EU.

Jouke Veldman, Marketing Director of Early Life Nutrition at FrieslandCampina Ingredients, expressed the company’s enthusiasm: “We’re absolutely thrilled that Hyvital^® Whey HA 300 has received this approval. This decision not only broadens the options available for developing formulas for infants, but also reinforces our commitment to meeting the highest industry standards. I would like to extend my gratitude to our dedicated R&D teams in Ingredients, Global Nutrition and Scientific & Regulatory Affairs. Their hard work and expertise were instrumental in securing this approval and achieving this important milestone. Our customers can trust that we continue to prioritize safety, quality, and innovation.”

The inclusion of Hyvital^® Whey HA 300 in the EU legislation further strengthens FrieslandCampina Ingredients’ position as a trusted leader in early life nutrition, with a focus on delivering high-quality solutions for infants.

Find out more about our hydrolysates or download the Hyvital^® Whey HA 300 product data sheet here.

Or read the latest European Commission’s publication which details the full approval.